Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | CPB2 | Q96IY4 | 8/20 | 0.49 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.43 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.43 |
| ▸ | FAP | Q12884 | 1/20 | 0.42 |
| ▸ | GNPAT | O15228 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29358709 | 1.00 | FOLH1 (0.54) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL29358689 | 1.00 | FOLH1 (0.54) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL1711313 | 1.00 | FOLH1 (0.54) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL29357446 | 1.00 | FOLH1 (0.54) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL29782763 | 0.97 | FOLH1 (0.51) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL29392005 | 0.95 | FOLH1 (0.47) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL16862514 | 0.94 | FOLH1 (0.49) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL16862515 | 0.94 | FOLH1 (0.49) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL30578949 | 0.93 | FOLH1 (0.48) | FOLH1CPB2SLC6A5GSRDPP4 | |
| SCHEMBL30093154 | 0.93 | FOLH1 (0.48) | FOLH1CPB2SLC6A5GSRDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2434 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144882-A1 | ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF | BIO-THERA SOLUTIONS, LTD. (CN) | 2026-05-28 | — | — | US | claimed |
| WO-2026103740-A1 | CEACAM5-ANTIGEN-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF AND USE THEREOF | 信达生物医药科技(杭州)有限公司 | 2026-05-21 | — | — | WO | claimed |
| EP-3972649-B1 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2026-05-13 | — | — | EP | claimed |
| CN-122028936-A | Antibody-drug conjugates | ADC疗法责任有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260124212-A1 | MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF | IMMUNOGEN INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260102507-A1 | CAMPTOTHECIN DERIVATIVE FOR TREATING OR PREVENTING CANCER AND ANTIBODY-DRUG CONJUGATE THEREOF | CHENGDU BRILLIANT PHARMACEUTICAL CO LTD (CN) | 2026-04-16 | — | — | US | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| US-20260061065-A1 | ANTIBODY DRUG CONJUGATES | NOVARTIS AG (CH) | 2026-03-05 | — | — | US | claimed |
| EP-4703389-A1 | ANTI-PTK7 ANTIBODY AND USES THEREOF | MabCare Therapeutics (CN) | 2026-03-04 | — | — | EP | claimed |
| EP-2173739-A1 | SUBSTITUTED CC-1065 ANALOGS AND THEIR CONJUGATES | Syntarga B.V. (NL) | 2010-04-14 | — | — | EP | claimed |
| US-20090318668-A1 | Water-Soluble CC-1065 Analogs and Their Conjugates | Georg-August-Universität Göttingen Stiftung öffentlichen Rechts (ohne Bereich Humanmedizin) (DE) | 2009-12-24 | — | — | US | claimed |
| CN-100522249-C | Elongated multiple spacers in activatable prodrugs | SINTAGAR B V (NL) | 2009-08-05 | — | — | CN | claimed |
| WO-2009017394-A1 | SUBSTITUTED CC-1065 ANALOGS AND THEIR CONJUGATES | SYNTARGA B.V. (NL) | 2009-02-05 | — | — | WO | claimed |
| EP-1994000-A2 | WATER-SOLUBLE CC-1065 ANALOGS AND THEIR CONJUGATES | Syntarga B.V. (NL) | 2008-11-26 | — | — | EP | claimed |
| US-7420029-B2 | Tissue-specific transporter inhibitor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-09-02 | — | — | US | claimed |
| WO-2007089149-A2 | WATER-SOLUBLE CC-1065 ANALOGS AND THEIR CONJUGATES | SYNTARGA B.V. (NL) | 2007-08-09 | — | — | WO | claimed |
| US-20040191211-A1 | Tissue-specific transporter inhibitor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2004-09-30 | — | — | US | claimed |
| CN-1511044-A | Elogated and multiple spacers in activatible prodrugs | — | 2004-07-07 | — | — | CN | claimed |
| EP-1405644-A1 | TISSUE-SPECIFIC TRANSPORTER INHIBITOR | Japan Science and Technology Agency (JP) | 2004-04-07 | — | — | EP | claimed |